CN104758318B - A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate - Google Patents

A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate Download PDF

Info

Publication number
CN104758318B
CN104758318B CN201510102291.XA CN201510102291A CN104758318B CN 104758318 B CN104758318 B CN 104758318B CN 201510102291 A CN201510102291 A CN 201510102291A CN 104758318 B CN104758318 B CN 104758318B
Authority
CN
China
Prior art keywords
liquid
acid
acidulant
oligosaccharide
compound formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510102291.XA
Other languages
Chinese (zh)
Other versions
CN104758318A (en
Inventor
单宝龙
陈雷
谷巍
王红
孙明杰
林显华
崔斌
王军
徐鹏
董佩佩
王春凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG BAOLAI-LEELAI BIO-ENGINEERING Co Ltd
Original Assignee
SHANDONG BAOLAI-LEELAI BIO-ENGINEERING Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG BAOLAI-LEELAI BIO-ENGINEERING Co Ltd filed Critical SHANDONG BAOLAI-LEELAI BIO-ENGINEERING Co Ltd
Priority to CN201510102291.XA priority Critical patent/CN104758318B/en
Publication of CN104758318A publication Critical patent/CN104758318A/en
Application granted granted Critical
Publication of CN104758318B publication Critical patent/CN104758318B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

It is by oligosaccharide acidulant liquid and probiotics fermention liquid by volume 1 the invention discloses a kind of compound formulation for reducing diarrhea of weaned piglets rate:(3-5) is mixed;Contain in the oligosaccharide acidulant liquid of every 1mL:Oxalic acid 2500-3500 μ g, tartaric acid 30-60 μ g, malic acid 50-100 μ g, lactic acid 4000-5500 μ g, citric acid 2500-4000 μ g, glucose 0.05-0.2g, oligoisomaltose 0.05-0.1g, oligofructose 0.02-0.06g, chitosan oligomer 0.08-0.15g;The probiotics fermention liquid be by lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid and clostridium butyricum fermentation liquid by volume (2-4):1 mixes.The invention also discloses the preparation methods of the reduction diarrhea of weaned piglets rate compound formulation.Compound formulation of the invention can reduce diarrhea of weaned piglets probability, reduce the death rate of piglet, improve the production performance and immune function of piglet.

Description

A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate
Technical field
The present invention relates to a kind of compound formulations and preparation method thereof for reducing diarrhea of weaned piglets rate.
Background technique
In recent years, pig breeding industry development in China's is very rapid, and the management of cultivation and large-scale degree are all improved.With Early weaning piglet skill has gradually been popularized in the countries and regions of the raising of pig production technical level, some pig breeding industry prosperities Art, but cross early-weaning can make piglet nutrition, environment and it is psychological generate stress, lead to feed intake reduction, growth retardation, weight Decline, diarrhea, in addition it is dead.It is reported that 30kg piglet below, annual diarrhea disease percentage 46.5%, the death rate 10.3%.Cause How this, prevent and treat one of the urgent task that diarrhea of weaned piglets has become current pig breeding industry.
Up to the present, domestic to mostly use antibiotic etc direct injection in the prevention and treatment of diarrhea of weaned piglets disease or add It is added in feed, with a large amount of appearance of antibody-resistant bacterium, it is ineffective to be frequently found existing chemicals control diarrhea, and this The a large amount of of a little drugs are enriched with the health for seriously threatening the mankind using livestock products drug residue is be easy to cause in human body;Epidemic disease Seedling is immune, though the antibody content in sow milk can be improved, the antibody duration is short, is not enough to protect the entire growth phase of piglet Diarrhea does not occur, and e. coli serotype is complicated, constantly variation, it is little immune piglet is produced effects;Chinese herbal medicine drug effect is slow Slowly, dosage is big, and palatability is poor, limits its application in weanling pig daily ration;The microelements such as high-copper, high zinc also have It is applied, but easily residual, pollution are big, easily lead to heavy metal poisoning;Enzyme preparation is also used, but position is excessively single, nothing Diarrhea caused by method is solved due to intestinal bacilli illness.Therefore, find it is a kind of diarrhea of weaned piglets rate can be effectively reduced, simultaneously The product for not endangering human health is imperative.
Summary of the invention:
In view of the deficiency of the prior art, the object of the present invention is to provide a kind of reduction diarrhea of weaned piglets rates Compound formulation and preparation method thereof, the compound formulation can reduce diarrhea of weaned piglets rate, reduce the death rate of piglet, improve piglet Production performance and immune function.
To achieve the above object, the present invention adopts the following technical scheme that:
A kind of compound formulation reducing diarrhea of weaned piglets rate, is by oligosaccharide acidulant liquid and probiotics fermention liquid by body Product ratio 1:(3-5) is mixed;
Contain in the oligosaccharide acidulant liquid of every 1mL:
Oxalic acid 2500-3500 μ g, tartaric acid 30-60 μ g, malic acid 50-100 μ g, lactic acid 4000-5500 μ g, citric acid 2500-4000 μ g, glucose 0.05-0.2g, oligoisomaltose 0.05-0.1g, oligofructose 0.02-0.06g, oligopolymerization chitosan Sugared 0.08-0.15g;
Preferably, contain in the oligosaccharide acidulant liquid of every 1mL:3000 μ g of oxalic acid, 50 μ g of tartaric acid, malic acid 60 μ g, 5000 μ g of lactic acid, citric acid 3000 μ g, glucose 0.1g, oligoisomaltose 0.05g, oligofructose 0.05g, oligomeric shell Glycan 0.1g.
Preferably, the chitosan oligomer is polymerized by 2-10 glycosidic bond.
The probiotics fermention liquid be by lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid and clostridium butyricum fermentation liquid by Volume ratio (2-4):1 mixes, and in the probiotics fermention liquid, the viable count of lactobacillus plantarum is more than or equal to 1 × 108The viable count of cfu/mL, Pediococcus pentosaceus are more than or equal to 1 × 108The viable count of cfu/mL, clostridium butyricum be greater than or Equal to 1 × 107cfu/mL。
Preferably, the probiotics fermention liquid is by lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid and clostridium butyricum Fermentation liquid by volume 2:1 mixes.
The lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid are by lactobacillus plantarum LP (Lactobacillus Plantarum), Pediococcus pentosaceus PP (Pediococcus pentosaceus PP) co-fermentation obtains, which is documented in An a kind of patent of invention " lactic acid bacteria semisolid fermentation product and technique for improving growth of animal performance " (CN of applicant In 102599348B), fermentation process is the same as " specific zymotechnique " step (1)-(4) in embodiment 3 in the patent;Wherein pentose piece Coccus PP (Pediococcus pentosaceus PP) is preserved in China typical culture collection center, and deposit number is CCTCC NO:M 2012029;Lactobacillus plantarum LP (Lactobacillus plantarum) is documented in another hair of applicant In bright patent " one plant of lactic acid bacteria that can be used for biological preservation and its application " (CN101914475 B), it is preserved in Chinese allusion quotation Type culture collection, deposit number are CCTCC NO:M 2010150.
The clostridium butyricum fermentation liquid is to ferment to obtain by clostridium butyricum (Clostridium butyricum) Cb-2, should Clostridium butyricum is documented in another patent of invention of applicant, and " one plant has the clostridium butyricum for the treatment of diarrhea effect and its as fourth In the application of sour sodium substitute " (102559550 B of CN), it is preserved in China typical culture collection center, deposit number For:CCTCC NO:M 2011384;Fermentation process is the same as " 4.6 prepare clostridium butyricum bacterium powder " part in embodiment 1 in the patent Step (i)-(v) ".
In the prescription of the compound formulation, oligosaccharide is small molecule carbohydrate, since it cannot be disappeared by alimentary canal endogenous enzymes Change, cannot also be utilized by harmful bacteria, thus beneficial bacterium growth, breeding can be promoted, so that balance intestinal flora, inhibits the hair of diarrhea It is raw.Probiotics fermention liquid has regulation intestinal flora balance, inhibits the breeding of the harmful bacterias such as Escherichia coli, salmonella, prevention The effect of diarrhea of weaned piglets.Acidulant is the monomer or mixture for referring to be added to organic acid and inorganic acid in feed, It is acted on mainly by improving gastrointestinal micro-flora, is inhibited the growth of harmful bacteria, is promoted the proliferation of beneficial bacterium;It adjusts in stomach PH value and the intestine evacuation velocity for slowing down stomach, to promote the digestion and absorption of nutriment;The palatability for improving feed, whets the appetite. Three's compounding can reduce diarrhea of weaned piglets rate.
The preparation method of the reduction diarrhea of weaned piglets rate compound formulation, steps are as follows:
(1) by oxalic acid, tartaric acid, malic acid, lactic acid, citric acid, glucose, oligoisomaltose, oligofructose and low Chitosan mixing, uses water as solvent, heats and stir, make it completely dissolved, cool down, and adjusting pH is 3.0-5.0, is made low Glycan acidulant liquid contains in the oligosaccharide acidulant liquid of every 1mL:Oxalic acid 2500-3500 μ g, tartaric acid 30-60 μ g, malic acid 50-100 μ g, lactic acid 4000-5500 μ g, citric acid 2500-4000 μ g, glucose 0.05-0.2g, oligoisomaltose 0.05- 0.1g, oligofructose 0.02-0.06g, chitosan oligomer 0.08-0.15g;
(2) by volume by lactobacillus plantarum LP, Pediococcus pentosaceus PP mixed fermentation liquid and clostridium butyricum Cb-2 fermentation liquid (2-4):1 mixes, in the probiotics fermention liquid, the work of lactobacillus plantarum LP, Pediococcus pentosaceus PP and clostridium butyricum Cb-2 Bacterium number is respectively greater than or is equal to 1 × 108cfu/mL、1×108Cfu/mL and 1 × 107cfu/mL;
(3) by probiotics fermention liquid made from oligosaccharide acidulant liquid made from step (1) and step (2) by volume 1: (3-5) mixing to get.
Preferably, in the step (3), oligosaccharide acidulant liquid and probiotics fermention liquid by volume 1:4 mixing.
Beneficial effects of the present invention:
(1) present invention is compounded using oligosaccharide, probiotics, acidulant for the first time, and wean can be effectively reduced by having developed The product of grice diarrhoea rate;Wherein oligosaccharide, probiotics, acidulant three synergistic effect, on the one hand, oligosaccharide is small molecule object Matter can be made full use of by probiotics, and without being consumed by harmful bacteria, final balance intestinal flora reduces the probability of happening of diarrhea;Separately On the one hand, lactic acid bacteria produces acid, reduces the quantity of pathogenic bacteria, and clostridium butyricum Antidiarrheic effect is good, the two is compound to reduce abdomen The generation rushed down;The third aspect, acidulant can reduce gut pH, promote lactic acid bacteria field planting, are conducive to producing enzyme, improve feed digestion Utilization rate.
(2) present invention selects clostridium butyricum, lactobacillus plantarum and Pediococcus pentosaceus to be compounded, and wherein clostridium butyricum is metabolized The organic acids such as butyric acid, acetic acid are generated, bacteriostasis rate is high;Lactobacillus plantarum, Pediococcus pentosaceus are enteron aisle dominant microflora, can be in enteron aisle Establish dominant microflora;Oligomeric functional sugar simultaneously can promote beneficial bacterium growth, breeding, not utilized by harmful bacteria, chitosan oligomer is also There is the effect of similar antibiotic, by adjusting intestine microenvironment, plays the anti-diarrhea effect of growth promotion.
(3) effect of compound formulation of the present invention is evaluated by excrement count plate and S-IgA assay As a result fruit proves that compound formulation of the invention can significantly reduce the diarrhea rate of weanling pig;Piglet average daily gain is improved, it is average Daily ingestion amount significantly reduces feedstuff-meat ratio, improves the production performance of piglet;Lactic acid bacterium number in excrement is dramatically increased, large intestine is reduced Bacillus quantity, balance intestinal flora;Weanling pig fecal energy and crude fat content are significantly reduced, efficiency of feed utilization is improved;It is aobvious It writes and improves excrement sIgA content, enhance mucosa-immune ability.
Detailed description of the invention
Fig. 1 a:It is illustrated for control group piglet excrement in embodiment 3, watery stools are more;
Fig. 1 b:It is illustrated for test group piglet excrement in embodiment 3, excrement forms, is harder;
Fig. 1 c:It is illustrated for Related product group excrement in embodiment 3, excrement is thin, soft stool.
Specific embodiment
The present invention is further illustrated in conjunction with the embodiments, it should which explanation, following the description is merely to explain this Invention, is not defined its content.
Embodiment 1:The compound acidulant screening test for preventing and treating diarrhea of weaned piglets
1 materials and methods
1.1 experimental design
Test is carried out in drink township Ba Fubafu farm of Ningyang County of Shandong Province township, selects the same kind of 30-33 age in days, weight phase Close weanling pig 90, is divided into control group (CK), test group I (F1) and test group II (F2), each group of 3 repetitions, each Repeat 10 pigs.Control group is drunk water daily feeds clear water, and test group I feeds compound acidulant formula 1 (water dilutes 10 times) daily, Test group II drinks water feeding compound acidulant formula 2 (10 times of water dilution) daily, continuously feeds 14d, changes into after feeding clear Water is normally fed, and observes 7d later, examines pig diarrhea situation.
Compound acidulant formula 1:Every 1mL compound acidulant 3000 μ g containing oxalic acid, 50 μ g of tartaric acid, 60 μ g of malic acid, cream Acid 5000 μ g, 3000 μ g of citric acid;
Compound acidulant formula 2:Every 1mL compound acidulant 300 μ g containing oxalic acid, 100 μ g of tartaric acid, 1000 μ g of lactic acid, second Acid 1000 μ g, 500 μ g of citric acid.
1.2 test daily rations
Daily ration basic components are corn 58%, dregs of beans 24%, wheat bran 3.8%, fish meal (import) 5%, whey powder 5%, plant Object oil 1%, mountain flour 0.7%, CaHCO31%, salt 0.2%, L lysine HCL 0.3%, premix 1%.Its nutritive water It puts down as CP (crude protein) 9.8%, Ca 0.87%, P 0.05%, lysine 1.31% (being mass percent).
1.3 feeding management
Daily feeding 4 times, is freely eaten, and when control group fed supplies clear water, test group I, test group II compound acidulant It drinks water and feeds after being diluted with water 10 times.Each pigsty of sweeping is given up 1 time sooner or later daily, every 7d cleaning and disinfection crib, apparatus 1 time, young Thin observation feeding and excrement situation of change.Test period is 21d, respectively in test 0d, 21d morning 9:00 weighs on an empty stomach, Calculate test group I, test group II and average daily gain, average daily gain, feedstuff-meat ratio of control group piglet etc..
1.4 diarrhea rates calculate
The daily diarrhea head number of piglet is recorded, is calculated:
Diarrhea rate=[circle day diarrhea piglet head number summation/(total head number × number of days of piglet)] × 100% grice diarrhoea journey Degree evaluating basis is shown in Table 1.When occur mild diarrhea be same day excrement under normal conditions, be calculated as diarrhea head time 1 time.
1 Scours index evaluating basis of table
1.5 faecal microbiotas count and trophic level measurement
When off-test, test group, control group take appropriate excrement to take back experimental determination faecal microbiota and nutritive water respectively Flat (energy, crude protein, crude fat etc.).Faecal microbiota is counted to be carried out using gradient dilution method, and the measurement of excrement trophic level uses Energy measuring device, crude protein, determinator for crude fats are measured.
The analysis of 1.6 data carries out data analyses using SPSS software, is as a result indicated with X ± S.
2 results and analysis
2.1 use the influence before and after compound acidulant to diarrhea of weaned piglets rate
Table 2 uses the influence before and after compound acidulant to diarrhea of weaned piglets rate
Note:Colleague's data shoulder is designated as the significant (P of different lowercase letter indication differences<0.05) identical lowercase, indicates Not significant (the P of difference>0.05), similarly hereinafter.
Each processing group diarrhea rate sees the above table 2.From table 2 it can be seen that each group diarrhea rate is all more serious before using acidulant, Near or above 20%, after drinking-water feeds acidulant, two test groups are all conducive to improve the digestive property of piglet, reduce The diarrhea rate of piglet.F1 group reduction diarrhea rate reaches 23.9%, F2 group reduction diarrhea rate and reaches 8.9%, and control group is not due to Any pharmaceutical preparation is added, grice diarrhoea rate is risen, it is possible thereby to illustrate compound acidulant to alleviation diarrhea of weaned piglets There is good effect.
Influence of 2.2 compound acidulants to Production Performance of Weaning Pigs
Influence of 3 compound acidulant of table to Production Performance of Weaning Pigs
Table 3 shows that compound acidulant F1, F2 are added in drinking-water can significantly improve the average opisthosoma of weanling pig again, averagely Daily gain, average daily gain, but the not significant (P of difference compared with the control group>0.05), F1 group significantly reduces feedstuff-meat ratio (P < 0.05).It is possible thereby to illustrate that compound acidulant can significantly improve the production performance of weanling pig.
Influence of 2.3 compound acidulants to weanling pig faecal microbiota
Influence of 4 compound acidulant of table to weanling pig faecal microbiota
Some researches show that Escherichia coli are the critical bacterial populations for leading to grice diarrhoea, and the decline of Escherichia coli quantity is conducive to son Microflora balance in pig stomach enteron aisle effectively prevents the generation of grice diarrhoea.From table 4, it can be seen that compound acidulant F1, F2 can significantly reduce the quantity (P < 0.05) of Escherichia coli, to effectively prevent the generation of grice diarrhoea.
2.4 compound acidulants influence crude protein of weanling pig excrement etc.
5 compound acidulant of table influences crude protein of weanling pig excrement etc.
As can be seen from Table 5, F1 group energy, crude protein are substantially less than control group (P < 0.05), illustrate that F1 improves albumen Utilization rate and S. E. A. promote the growth of pig;F2 group crude protein is substantially less than control group (P < 0.05), remaining is each Not significant (the P of component difference>0.05).F1, F2 group promote the growth of pig, reduce energy and crude protein water in excrement It is flat.
3 conclusions
From above-mentioned test result it can be concluded that, compound acidulant can in various degree promotion piglet growth, reduce enteron aisle In Escherichia coli quantity, the generation of effective preventing post-weaning diarrhea, and test group I (F1) be better than test group II (F2).
Embodiment 2:A kind of preparation for the compound formulation reducing diarrhea of weaned piglets rate
The compound formulation is by oligosaccharide acidulant liquid and probiotics fermention liquid by volume 1:4 mix;
Wherein, oligosaccharide acidulant liquid be by embodiment 1 preferably go out compound acidulant formula 1 and oligosaccharide compounding and At containing in the oligosaccharide acidulant liquid of every 1mL:3000 μ g of oxalic acid, 50 μ g of tartaric acid, 60 μ g of malic acid, 5000 μ g of lactic acid, lemon Lemon acid 3000 μ g, glucose 0.1g, oligoisomaltose 0.05g, oligofructose 0.05g, chitosan oligomer 0.1g;
Glucose, oligoisomaltose, oligofructose and chitosan oligomer are commercial product.
Probiotics fermention liquid is by lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid and clostridium butyricum fermentation liquid by volume Than 2:1 mixes.Lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid are by lactobacillus plantarum LP (Lactobacillus Plantarum), Pediococcus pentosaceus PP (Pediococcus pentosaceus PP) co-fermentation obtains, which is documented in An a kind of patent of invention " lactic acid bacteria semisolid fermentation product and technique for improving growth of animal performance " (CN of applicant 102599348 B) in, fermentation process is with " specific zymotechnique " step (1)-(4) in embodiment 3 in the patent, wherein pentose Piece coccus PP (Pediococcus pentosaceus PP) is preserved in China typical culture collection center, and deposit number is CCTCC NO:M 2012029;Lactobacillus plantarum LP (Lactobacillus plantarum) is documented in another hair of applicant In bright patent " one plant of lactic acid bacteria that can be used for biological preservation and its application " (101914475 B of CN), it is preserved in Chinese allusion quotation Type culture collection, deposit number are CCTCC NO:M 2010150.
Clostridium butyricum fermentation liquid is to ferment to obtain by clostridium butyricum (Clostridium butyrium) Cb-2, the butyric acid shuttle Bacterium is documented in another patent of invention of applicant, and " one plant has the clostridium butyricum for the treatment of diarrhea effect and its replaces as sodium butyrate In the application of Dai Pin " (102559550 B of CN), it is preserved in China typical culture collection center, deposit number is:CCTCC NO:M 2011384;Fermentation process is the same as in embodiment 1 in the patent the step of " 4.6 prepare clostridium butyricum bacterium powder " part (i)- (v)。
Specifically preparation process is:
By oxalic acid, tartaric acid, malic acid, lactic acid, citric acid, glucose, oligoisomaltose, oligofructose and oligomeric shell Glycan mixing, uses water as solvent, heats and stir, make it completely dissolved, cool down, and adjusting pH is 3.0-5.0, and oligosaccharide is made Acidulant liquid contains in the oligosaccharide acidulant liquid of every 1mL:3000 μ g of oxalic acid, 50 μ g of tartaric acid, 60 μ g of malic acid, lactic acid 5000 μ g, citric acid 3000 μ g, glucose 0.1g, oligoisomaltose 0.05g, oligofructose 0.05g, chitosan oligomer 0.1g;
By lactobacillus plantarum LP, Pediococcus pentosaceus PP mixed fermentation liquid and clostridium butyricum Cb-2 fermentation liquid by volume 2:1 Probiotics fermention liquid is made in mixing, and wherein lactobacillus plantarum LP viable count is 1 × 108Cfu/mL, Pediococcus pentosaceus PP viable count It is 1 × 108Cfu/mL, clostridium butyricum Cb-2 viable count are 1 × 107cfu/mL;
By oligosaccharide acidulant liquid obtained and probiotics fermention liquid by volume 1:4 mixing to get.
Embodiment 3:Compound formulation prevents and treats diarrhea of weaned piglets verification test
1 materials and methods
1.1 experimental design
Test is carried out in drink township Ba Fubafu farm of Ningyang County of Shandong Province township, selects the same kind of 30-33 age in days, weight phase Close weanling pig 90 is divided into control group, test group, Related product group, each group of 3 repetitions, 10 pigs of each repetition.It is right According to the group clear water of drinking-water feeding daily, compound formulation (water dilutes 10 times) prepared by test group drinking-water feeding embodiment 2, Related product The general raw edge (water dilutes 10 times) of group feeding, which is purchased from Henan Pu Nier Biology Pharmacy Co., Ltd.
1.2 test daily rations, management, evaluation, data analysis are referring to embodiment 1.
2 results and analysis
Influence of 2.1 compound formulations to diarrhea of weaned piglets rate
Influence of 6 compound formulation of table to diarrhea of weaned piglets rate
Diarrhea rate is an important indicator for evaluating diarrhea of weaned piglets.Death does not occur for this test whole process, tests Group adds compound formulation of the invention by drinking-water to prevent and treat diarrhea of weaned piglets.As can be seen from Table 6, compared with the control group, Test group can significantly reduce 27% (P of grice diarrhoea rate<0.05), Related product significantly reduces 11.34% (P of grice diarrhoea rate< 0.05).Compared with Related product group, test group significantly reduces 15.66% (P of grice diarrhoea rate<0.05), illustrate reducing wean In terms of grice diarrhoea rate, test group effect is more excellent.
Influence of 2.2 compound formulations to Production Performance of Weaning Pigs
Influence of 7 compound formulation of table to Production Performance of Weaning Pigs
As can be seen from Table 7, compared with the control group, test group can significantly improve the average daily gain 36.4% of weanling pig (P<0.05) 13.7% (P of feedstuff-meat ratio, is reduced<0.05);Related product group difference is not significant (P > 0.05);With Related product Group is compared, and test group significantly improves 25% (P of average daily gain<0.05) 12% (P of feedstuff-meat ratio, is significantly reduced<0.05), illustrate to try It is more excellent to test group effect in terms of improving Production Performance of Weaning Pigs.
Influence of 2.3 compound formulations to weanling pig faecal microbiota
Influence of 8 compound formulation of table to weanling pig faecal microbiota
As can be seen from Table 8, compared with the control group, lactic acid bacterium number dramatically increases (P in test group excrement<0.05), greatly Enterobacteria quantity significantly reduces (P<0.05);Related product group does not show lactic acid bacteria, the influence of Escherichia coli quantity in piglet excrement It writes (P > 0.05);Compared with Related product group, test group is remarkably promoting lactic acid bacteria intestinal colonisation, is inhibiting Escherichia coli breeding More excellent (the P of aspect effect<0.05).
Influence of 2.4 compound formulations to weanling pig fecal energy, crude protein, crude fat
Influence of 9 compound formulation of table to weanling pig fecal energy, crude protein, crude fat
As can be seen from Table 9, compared with the control group, test group weanling pig fecal energy, crude fat significantly reduce (P< 0.05), the not significant (P of crude protein difference>0.05);Related product group to weanling pig fecal energy, crude protein, crude fat shadow Ring not significant (P>0.05);Compared with Related product group, test group piglet fecal energy, crude fat significantly reduce (P< 0.05) digestive utilization ratio of feed, is improved.
Influence of 2.5 compound formulations to weanling pig excrement sIgA content
Influence of 10 compound formulation of table to weanling pig excrement sIgA content
As can be seen from Table 10, compared with the control group, test group excrement sIgA content significantly increases 20.8% (P<0.05), Illustrate that test group can significantly improve piglet excrement sIgA content, promotes mucosa-immune, to improve the immune water of weanling pig It is flat;Related product group influences not significant (P to sIgA content>0.05);Test group sIgA content is significantly improved than Related product group About 18.7% (P<0.05), in terms of enhancing mucosa-immune, test group effect is more preferable.
3 discuss
Influence of 3.1 compound formulations to diarrhea of weaned piglets rate
Grice diarrhoea is influenced by many factors.Diarrhea be due to enteropahtogenic microganism imbalance caused by, it is of the invention Result of study discovery, the compound formulation that drinking-water addition is mixed by oligosaccharide, acidulant and probiotics can significantly reduce wean Grice diarrhoea rate 27%, and Related product is only 11.34%, is reduced using the diarrhea rate after compound formulation than Related product group 15.66%, it is seen that the compound formulation of the invention better effect in terms of reducing diarrhea of weaned piglets rate.
Influence of 3.2 compound formulations to Production Performance of Weaning Pigs
The discovery of this result of study, compared with the control group, which significantly improves average daily gain 36.4%, reduces material Meat is than 13.7%, and compared with Related product group, compound formulation significantly improves average daily gain 25%, reduces feedstuff-meat ratio 15.8%, It can be seen that the compound formulation improves the production performance of weanling pig, it may be possible to which, since compound formulation has sour taste, stimulation is resolved The appetite of milk piglet improves piglet daily gain, reduces the reason of feedstuff-meat ratio.
Influence of 3.3 compound formulations to weanling pig faecal microbiota
In the formula of compound formulation of the invention:Oligosaccharide, probiotics, acidulant can improve microbiota in enteron aisle System, inhibits the growth of harmful bacteria, promotes the proliferation of beneficial bacterium.Firstly, acidulant can reduce the pH value of gastrointestinal tract, inhibit pathogen Breeding regeneration;Secondly, the addition of probiotics can generate positive effect to the field planting of beneficial bacterium in enteron aisle;Finally, oligomeric Sugar is in addition to it can supplement certain energy, moreover it is possible to which the feature for showing similar antibiotic inhibits the growth of a variety of pathogens.Three has Effect reduces the quantity of pathogenic entero becteria, to ensure that the health of enteron aisle.Test also turns out that test group (drinks compound formulation group) Microbiota in enteron aisle is improved, the growth of harmful bacteria is inhibited, promotes the proliferation of beneficial bacterium.
Influence of 3.4 compound formulations to weanling pig excrement trophic level
It to the utilization rate of feed is realized by many factors that the compound formulation, which can be improved piglet,.Firstly, reducing Various enzymatic activitys in stomach can be improved in acidity;Secondly, the addition of probiotics also functions to certain promotion to the breeding of bacillus Effect;Again, production acid, the bacteriostasis efficacy of clostridium butyricum are also beneficial to the utilization of feed;This test data shows test group excrement Middle energy, fat are remarkably decreased, and illustrate that the addition of the compound formulation can improve efficiency of feed utilization.
Influence of 3.5 compound formulations to weanling pig excrement sIgA content
Secretory IgA, that is, sIgA is the immune main antibody of body mucous membrane local anti-infective.Therefore also known as mucous membrane local antibody, The high and low energy of its content represents the level of mucosa-immune.A large number of experiments show that enterobacteriaceae can be adjusted after animal probiotic oral Group makes gastrointestinal micro-flora be in optimal equilibrium state, activates associated lymphoid tissue in intestinal mucosa, makes sIgA antibody-secreting Enhancing.The discovery of this test result, compared with control group, Related product group, test group compound formulation significantly improves sIgA content, Illustrate that the compound formulation can enhance mucosa-immune power, improves body's immunity and premunition.
4 conclusions
Compound formulation of the invention can significantly reduce the diarrhea rate of weanling pig compared with control group, Related product group; Piglet average daily gain is significantly improved, feedstuff-meat ratio is significantly reduced, improves the production performance of piglet;Dramatically increase lactic acid bacteria in excrement Quantity reduces Escherichia coli quantity, balance intestinal flora;Weanling pig fecal energy and crude fat content are significantly reduced, is improved Efficiency of feed utilization;Excrement sIgA content is significantly improved, mucosa-immune power is improved;Eventually by above-mentioned comprehensive function, this is compound Preparation reduces the diarrhea rate of weanling pig.

Claims (6)

1. a kind of compound formulation for reducing diarrhea of weaned piglets rate, which is characterized in that be by oligosaccharide acidulant liquid and probiotics Fermentation liquid by volume 1:(3-5) is mixed;
Contain in the oligosaccharide acidulant liquid of every 1mL:
Oxalic acid 2500-3500 μ g, tartaric acid 30-60 μ g, malic acid 50-100 μ g, lactic acid 4000-5500 μ g, citric acid 2500- 4000 μ g, glucose 0.05-0.2g, oligoisomaltose 0.05-0.1g, oligofructose 0.02-0.06g, chitosan oligomer 0.08-0.15g;
The probiotics fermention liquid is by lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid and clostridium butyricum fermentation liquid by volume Than (2-4):1 mixes;
It is CCTCC NO that the lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid, which are by deposit number,:The plant of M 2010150 Lactobacillus LP and deposit number are CCTCC NO:The Pediococcus pentosaceus PP co-fermentation of M 2012029 obtains;The clostridium butyricum It is CCTCC NO that fermentation liquid, which is by deposit number,:The clostridium butyricum Cb-2 of M 2011384 ferments to obtain;
The compound formulation is prepared by the following method to obtain:
(1) by oxalic acid, tartaric acid, malic acid, lactic acid, citric acid, glucose, oligoisomaltose, oligofructose and oligomeric shell Glycan mixing, uses water as solvent, heats and stir, make it completely dissolved, cool down, and adjusting pH is 3.0-5.0, and oligosaccharide is made Acidulant liquid;
(2) by lactobacillus plantarum LP, Pediococcus pentosaceus PP mixed fermentation liquid and clostridium butyricum Cb-2 fermentation liquid (2- by volume 4):1 mixing, is made probiotics fermention liquid;
(3) by probiotics fermention liquid made from oligosaccharide acidulant liquid made from step (1) and step (2) by volume 1:(3- 5) mix to get.
2. a kind of compound formulation for reducing diarrhea of weaned piglets rate as described in claim 1, which is characterized in that the probiotics Fermentation liquid is by lactobacillus plantarum, Pediococcus pentosaceus mixed fermentation liquid and clostridium butyricum fermentation liquid by volume 2:1 mixes.
3. a kind of compound formulation for reducing diarrhea of weaned piglets rate as described in claim 1, which is characterized in that the institute of every 1mL It states and contains in oligosaccharide acidulant liquid:3000 μ g of oxalic acid, 50 μ g of tartaric acid, 60 μ g of malic acid, 5000 μ g of lactic acid, citric acid 3000 μ g, glucose 0.1g, oligoisomaltose 0.05g, oligofructose 0.05g, chitosan oligomer 0.1g.
4. a kind of compound formulation for reducing diarrhea of weaned piglets rate as described in claim 1, which is characterized in that the oligomeric shell Glycan is polymerized by 2-10 glycosidic bond.
5. a kind of preparation method for the compound formulation for reducing diarrhea of weaned piglets rate, which is characterized in that steps are as follows:
(1) by oxalic acid, tartaric acid, malic acid, lactic acid, citric acid, glucose, oligoisomaltose, oligofructose and oligomeric shell Glycan mixing, uses water as solvent, heats and stir, make it completely dissolved, cool down, and adjusting pH is 3.0-5.0, and oligosaccharide is made Acidulant liquid contains in the oligosaccharide acidulant liquid of every 1mL:Oxalic acid 2500-3500 μ g, tartaric acid 30-60 μ g, malic acid 50- 100 μ g, lactic acid 4000-5500 μ g, citric acid 2500-4000 μ g, glucose 0.05-0.2g, oligoisomaltose 0.05- 0.1g, oligofructose 0.02-0.06g, chitosan oligomer 0.08-0.15g;
(2) by lactobacillus plantarum LP, Pediococcus pentosaceus PP mixed fermentation liquid and clostridium butyricum Cb-2 fermentation liquid (2- by volume 4):1 mixing, is made probiotics fermention liquid, wherein the viable count of lactobacillus plantarum LP, Pediococcus pentosaceus PP and clostridium butyricum Cb-2 Respectively greater than or equal to 1 × 108cfu/mL、1×108Cfu/mL and 1 × 107cfu/mL;The lactobacillus plantarum, pentose piece It is CCTCC NO that coccus mixed fermentation liquid, which is by deposit number,:The lactobacillus plantarum LP and deposit number of M 2010150 is CCTCC NO:The Pediococcus pentosaceus PP co-fermentation of M 2012029 obtains;It is CCTCC that the clostridium butyricum fermentation liquid, which is by deposit number, NO:The clostridium butyricum Cb-2 of M 2011384 ferments to obtain;
(3) by probiotics fermention liquid made from oligosaccharide acidulant liquid made from step (1) and step (2) by volume 1:(3- 5) mix to get.
6. a kind of preparation method of compound formulation for reducing diarrhea of weaned piglets rate as claimed in claim 5, which is characterized in that In step (3), oligosaccharide acidulant liquid and probiotics fermention liquid by volume 1:4 mixing.
CN201510102291.XA 2015-03-06 2015-03-06 A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate Active CN104758318B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510102291.XA CN104758318B (en) 2015-03-06 2015-03-06 A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510102291.XA CN104758318B (en) 2015-03-06 2015-03-06 A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate

Publications (2)

Publication Number Publication Date
CN104758318A CN104758318A (en) 2015-07-08
CN104758318B true CN104758318B (en) 2018-11-30

Family

ID=53640647

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510102291.XA Active CN104758318B (en) 2015-03-06 2015-03-06 A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate

Country Status (1)

Country Link
CN (1) CN104758318B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105248877B (en) * 2015-09-11 2018-10-02 山东宝来利来生物工程股份有限公司 A kind of micro-ecological compound preparation with immune enhancing function
CN105360665A (en) * 2015-11-16 2016-03-02 广州暨南生物医药研究开发基地有限公司 Anti-diarrhea Chinese herbal medicine feed additive for weaned piglets and preparation method thereof
CN106343189B (en) * 2016-08-26 2019-11-08 湖南百宜饲料科技有限公司 A kind of the fermentation semi-fluid body feedstuff and its preparation method of newborn piglet
CN106509455A (en) * 2016-11-10 2017-03-22 四川理工学院 Composite type synbiotic microecological preparation for rabbits and preparation method of composite type synbiotic microecological preparation
CN106509468A (en) * 2016-11-10 2017-03-22 四川理工学院 Composite type synbiotic microecological preparation for chickens and preparation method of composite type synbiotic microecological preparation
CN106720938A (en) * 2016-11-10 2017-05-31 四川理工学院 A kind of compound symphysis unit probiotics and preparation method thereof
CN106566791A (en) * 2016-11-10 2017-04-19 四川理工学院 Porcine compound synbiotics micro-ecological preparation and preparation method thereof
CN106689753A (en) * 2017-01-04 2017-05-24 陈雨 Weaned piglet feed compound preparation, feed containing the compound preparation and application of the feed
CN108391758A (en) * 2018-04-25 2018-08-14 广西康佳龙农牧集团有限公司 Milking sow compound Synbiotics
CN109136126B (en) * 2018-08-21 2021-04-13 云南农业大学 Pediococcus pentosaceus for preventing diarrhea of weaned piglets
CN109770046A (en) * 2019-03-08 2019-05-21 刘坚 A kind of sucking pig wean pannage and preparation method thereof
CN111657402A (en) * 2020-06-30 2020-09-15 武汉合缘绿色生物股份有限公司 Feed additive for regulating intestinal function of pigs and preparation method thereof
CN112586621A (en) * 2020-12-15 2021-04-02 南京致润生物科技有限公司 Functional fermented yoghourt special for piglets and preparation method thereof
CN112618579B (en) * 2020-12-24 2022-02-15 南京农业大学 Compound probiotic preparation for preventing and treating piglet diarrhea as well as preparation method and application thereof
CN115227696A (en) * 2022-07-29 2022-10-25 广州傲农生物科技有限公司 Compound acidifier for resisting diarrhea and promoting growth of piglets as well as preparation method and application thereof
CN115634263B (en) * 2022-10-20 2023-11-21 东北农业大学 Composition for preventing and treating animal diarrhea, alkaline mineral compound preparation, and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100450375C (en) * 2006-06-09 2009-01-14 大连轻工业学院 Composite microorganism type forage additives and its prodn. method
CN102488117B (en) * 2011-12-22 2013-06-19 南京农业大学 Combination used for preventing and treating newborn pig diarrhea and preparation method and application thereof
RU2585851C2 (en) * 2011-12-29 2016-06-10 Хилл'С Пет Ньютришн, Инк. Compositions and methods for modification of gastro-intestinal flora
CN102559550B (en) * 2011-12-30 2013-09-25 山东宝来利来生物工程股份有限公司 Clostridium butyricum having diarrhea treating effect and application of clostridium butyricum as substitute of sodium butyrate
CN102599348B (en) * 2012-03-26 2013-08-14 山东宝来利来生物工程股份有限公司 Lactic acid bacteria semi-solid fermentation product for increasing growth performance of animals and process
CN102823771A (en) * 2012-09-07 2012-12-19 北京大北农科技集团股份有限公司 Biological active acidifying agent for piglets, premix compound and compound
CN102870987B (en) * 2012-09-19 2013-12-11 广州立达尔生物科技股份有限公司 Green feed additive used for improving development of intestinal canal of infant animal
CN102960560B (en) * 2012-11-23 2014-09-10 重庆优宝生物技术有限公司 Composite acidifier for reducing post-weaning diarrhea rate
CN103876145B (en) * 2014-04-01 2016-06-01 吉林大学 A kind of probiotics micro-ecological tablet and its preparation method
CN104171363B (en) * 2014-07-02 2016-06-01 中泰和(北京)科技发展有限公司 A kind of fodder additives improving grice diarrhoea rate

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
复合微生态制剂对哺乳仔猪生产性能和粪便菌群的影响;谢全喜 等;《饲料博览》;20141225(第12期);第29-32页 *
复合益生菌和纤维寡糖对断奶仔猪生长性能、粪便微生物及血清指标的影响;王杰 等;《动物营养学报》;20160301;第28卷(第3期);第881-990页 *
复合酸化剂对断奶仔猪生产性能和饲料表观消化率的影响;王杰 等;《黑龙江畜牧兽医》;20100710(第7期);第77-79页 *
微生态制剂在断奶仔猪生产上的应用研究;徐海燕 等;《青岛农业大学学报(自然科学版)》;20110615;第28卷(第2期);第126-129页 *
益生菌对断奶仔猪生长性能、免疫器官指数及胃肠道pH的影响;周盟 等;《动物营养学报》;20140106;第26卷(第2期);第445-452页 *
酸化剂、益生素和寡糖对断奶仔猪粪中微生物菌群和免疫功能的影响及其互作效应研究;陈代文 等;《动物营养学报》;20060930;第18卷(第3期);第172-178页 *

Also Published As

Publication number Publication date
CN104758318A (en) 2015-07-08

Similar Documents

Publication Publication Date Title
CN104758318B (en) A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate
Lauzon et al. Probiotics and prebiotics: concepts, definitions and history
CN100349575C (en) Nutritional composition
CN106619743A (en) Probiotic solid drink with hypoglycaemic effect and preparation method of probiotic solid drink
Zduńczyk et al. Determinants and effects of postileal fermentation in broilers and turkeys part 1: gut microbiota composition and its modulation by feed additives
CN113498433B (en) Composition for preventing, improving or treating obesity or fatty liver disease comprising leuconostoc citrate WiKim0104
CN108112987A (en) A kind of functional preparation for adjusting gastrointestinal health and its preparation method and application
CN105410365B (en) A kind of feed addictive of alternative antibiotic and its application
CN104206789B (en) It is a kind of to be used to prevent mastitis for milk cows and the feed addictive of brucellosis and preparation method thereof
CN109771470A (en) A kind of composition and preparation method thereof containing probiotics
CN102524539B (en) Animal health preserver composition and preparation process for animal health preserver composition
JP6596135B2 (en) Composition for improving intestinal environment, inhibiting weight gain by ingesting a high-fat diet, or inhibiting H. pylori
CN105685970A (en) Compound nutritious food capable of improving whole digestive tract
CN109475151A (en) Control the immunological regulation of harmful bacteria and growth promotion composition and application thereof in intestinal microbiota
CN106955335A (en) It is a kind of to prevent Chinese medicine microecological preparation of calf diarrhea and preparation method thereof
CN106509440A (en) Health-care feed additive for multiparous sows
CN106417989A (en) Probiotic composition for aquatic animal feed, preparation method and application thereof
CN100482104C (en) Process for preparing lactic acid bacteria oral liquor
CN106689753A (en) Weaned piglet feed compound preparation, feed containing the compound preparation and application of the feed
CN106922997A (en) A kind of pig feed additive of efficient gastrointestinal mucosa repair function
CN110326708A (en) A kind of functionality additive package and its application
CN105076830A (en) Compound feed for channa maculate and preparation method of compound feed
US20210177028A1 (en) Improved human food product
CN114344341B (en) Composite probiotic composition with intestinal tract regulating effect and preparation method and application thereof
KR101838280B1 (en) Leuconostoc citreum WIKIM56 having anti-arthritis activity and composition for comprising the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant